PMID: 8582512Oct 1, 1995Paper

The menopause revisited

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
G Samsioe

Abstract

The continuing growth of female life expectancy has resulted in a marked increase of women in years beyond the menopause. Women can nowadays expect to live one-third of their lives in a potential hormonal deficiency state. Women over 50 comprise 17% of the total population of any country in the modern western world. Any decision regarding their health issues will have a great impact on our limited health care resources. There is no doubt that estrogen replacement therapy effectively mitigates hot flushes and other vasomotor symptoms and more effectively so than other treatment modalities. Vasomotor symptoms affect more than half of the female population around the menopause with a mean duration of 2-3 years. When used to treat vasomotor symptoms hormone replacement therapy has repeatedly been shown to be cost effective. It is also well documented that hormone replacement therapy effectively prevents bone loss and osteoporotic fractures as well as heart disease. The majority of cases of both fractures and heart disease occur at ages over 75 and concern has been expressed if treatment from the menopausal age to the onset of fractures or heart disease is cost effective with regard to the perceived increase in risk of side effects,...Continue Reading

References

Oct 1, 1992·British Journal of Obstetrics and Gynaecology·M FalkebornT Naessén
Jan 1, 1992·Maturitas·S M McKinlayJ G Posner
Apr 21, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·P S Eriksen, H Rasmussen
Dec 1, 1991·Baillière's Clinical Obstetrics and Gynaecology·A N Tosteson, M C Weinstein
Sep 12, 1991·The New England Journal of Medicine·M J StampferC H Hennekens
Jun 1, 1989·Journal of Epidemiology and Community Health·S G ThompsonG Greenberg
Aug 1, 1988·American Journal of Obstetrics and Gynecology·B E HendersonR K Ross
Jan 1, 1984·Acta Obstetricia Et Gynecologica Scandinavica·C S Iosif, Z Bekassy
May 15, 1993·Lancet·P CollinsP A Poole-Wilson
May 14, 1994·BMJ : British Medical Journal·W F PosthumaJ P Vandenbroucke
Sep 9, 1993·The New England Journal of Medicine·C Svanborg
Oct 14, 1993·The New England Journal of Medicine·D T FelsonJ J Anderson

❮ Previous
Next ❯

Citations

Mar 26, 2013·Endocrine·Katherine EspositoDario Giugliano
Jul 23, 1998·Journal of Nurse-midwifery·M E Rousseau
Feb 8, 2000·Maturitas·M Guy
May 24, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Elizabeth Farrell
Aug 8, 2001·The Australasian Journal of Dermatology·N Wines, E Willsteed
Sep 14, 2001·Journal of the American Geriatrics Society·D A NewellJ L Freeman
Jun 28, 2008·Nutrition and Cancer·Nomeli P NunezStephen D Hursting
Jul 28, 2012·Indian Journal of Endocrinology and Metabolism·Puneet MutnejaGaurav Sharma
Mar 16, 2004·Journal of Clinical Periodontology·Dimitris N Tatakis, Leonardo Trombelli
Apr 28, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Henry G Burger
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·C M Farquhar, A H MacLennan
Mar 15, 2005·Archives of Andrology·K NishimuraS Nagano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.